Lorena Castellon-Alba

Barcelona, CT 08041, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Nanotoxin induces in situ pyroptosis to sensitize αPD1 to ablate metastases in microsattellite stable colorectal cancer.

Nanotoxin induces in situ pyroptosis to sensitize αPD1 to ablate metastases in microsattellite stable colorectal cancer.

Journal: Pharmacological research
Published: July 22, 2025

Precision targeting of CXCR4+ leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model.

Precision targeting of CXCR4+ leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 15, 2025

Subcutaneous administration of an endocrine-mimetic platform allows for prolonged tumor uptake of a tumor targeting protein.

Subcutaneous administration of an endocrine-mimetic platform allows for prolonged tumor uptake of a tumor targeting protein.

Journal: International journal of pharmaceutics
Published: July 14, 2025

Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates.

Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates.

Journal: Materials today. Bio
Published: June 19, 2025

A Targeted Nanotoxin Inhibits Colorectal Cancer Growth Through Local Tumor Pyroptosis and Eosinophil Infiltration and Degranulation.

A Targeted Nanotoxin Inhibits Colorectal Cancer Growth Through Local Tumor Pyroptosis and Eosinophil Infiltration and Degranulation.

Journal: International journal of nanomedicine
Published: October 03, 2024

KDEL-mediated modulation of intracellular trafficking in cell-targeted protein drugs.

KDEL-mediated modulation of intracellular trafficking in cell-targeted protein drugs.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: September 02, 2024

CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas.

CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas.

Journal: Diagnostics (Basel, Switzerland)
Published: April 25, 2024

High-precision targeting and destruction of cancer-associated PDGFR-β+ stromal fibroblasts through self-assembling, protein-only nanoparticles.

High-precision targeting and destruction of cancer-associated PDGFR-β+ stromal fibroblasts through self-assembling, protein-only nanoparticles.

Journal: Acta biomaterialia
Published: May 25, 2023

Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticles.

Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticles.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 04, 2023

Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models.

Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models.

Journal: Cancers
Published: December 05, 2022

Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease.

Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease.

Journal: Biomedicines
Published: May 24, 2022

GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases.

GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases.

Journal: Drug delivery
Published: May 09, 2022
Showing 1-12 of 31

Last Updated: 09/26/2026